Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines

I. Brown, K. W. J. Wahle, M. G. Cascio, R. Smoum-Jaouni, R. Mechoulam, R. G. Pertwee, S. D. Heys

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Omega-3 (n-3) fatty acids inhibit breast and prostate cancer cell growth. We previously showed that N-acylethanolamine derivatives of n-3 (n-3-NAE) are endocannabinoids, which regulate cancer cell proliferation. These n-3-NAE are synthesised in certain cells/tissues, after supplementing with fatty acids, however, no one has assessed whether and to what extent this occurs in cancer cells. We determined levels of endogenous n-3-NAEs in hormone sensitive and insensitive prostate and breast cancer cells and subsequent effects on other endocannabinoids (anandamide and 2-arachidonoylglycerol), before and after supplementing with DHA and EPA fatty acids, using HPLC tandem mass spectrometry. This is the first study reporting that n-3-NAEs are synthesised from their parent n-3 fatty acids in cancer cells, regardless of tumour type, hormone status or the presence of fatty acid amide hydrolase. This could have important implications for the use of n-3 fatty acids as therapeutic agents in breast and prostate cancers expressing cannabinoid receptors.
LanguageEnglish
Pages305-310
Number of pages6
JournalProstaglandins, Leukotrienes and Essential Fatty Acids
Volume85
Issue number6
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Omega-3 Fatty Acids
Endocannabinoids
Prostatic Neoplasms
Cells
Breast Neoplasms
Cell Line
Fatty Acids
Hormones
Cannabinoid Receptors
Cell proliferation
Cell growth
Neoplasms
Mass spectrometry
Tumors
Tissue
Derivatives
Tandem Mass Spectrometry
High Pressure Liquid Chromatography
Cell Proliferation
N-acylethanolamines

Keywords

  • eicosapentaenoic acid
  • cannabinoid receptors
  • anandamide
  • ethanolamides
  • proliferation
  • apoptosis
  • supplementation
  • n-3 pufa
  • prostate cancer
  • endocannabinoid
  • brain
  • growth
  • breast cancer
  • n-acylethanolamine
  • polyunsaturated fatty-acids

Cite this

@article{63772ac74ccc49dd98dc5597c7084cb8,
title = "Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines",
abstract = "Omega-3 (n-3) fatty acids inhibit breast and prostate cancer cell growth. We previously showed that N-acylethanolamine derivatives of n-3 (n-3-NAE) are endocannabinoids, which regulate cancer cell proliferation. These n-3-NAE are synthesised in certain cells/tissues, after supplementing with fatty acids, however, no one has assessed whether and to what extent this occurs in cancer cells. We determined levels of endogenous n-3-NAEs in hormone sensitive and insensitive prostate and breast cancer cells and subsequent effects on other endocannabinoids (anandamide and 2-arachidonoylglycerol), before and after supplementing with DHA and EPA fatty acids, using HPLC tandem mass spectrometry. This is the first study reporting that n-3-NAEs are synthesised from their parent n-3 fatty acids in cancer cells, regardless of tumour type, hormone status or the presence of fatty acid amide hydrolase. This could have important implications for the use of n-3 fatty acids as therapeutic agents in breast and prostate cancers expressing cannabinoid receptors.",
keywords = "eicosapentaenoic acid, cannabinoid receptors, anandamide , ethanolamides, proliferation, apoptosis, supplementation, n-3 pufa, prostate cancer, endocannabinoid, brain, growth, breast cancer, n-acylethanolamine, polyunsaturated fatty-acids",
author = "I. Brown and Wahle, {K. W. J.} and Cascio, {M. G.} and R. Smoum-Jaouni and R. Mechoulam and Pertwee, {R. G.} and Heys, {S. D.}",
year = "2011",
month = "12",
doi = "10.1016/j.plefa.2011.09.007",
language = "English",
volume = "85",
pages = "305--310",
journal = "Prostaglandins, Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
number = "6",

}

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. / Brown, I.; Wahle, K. W. J.; Cascio, M. G.; Smoum-Jaouni, R.; Mechoulam, R.; Pertwee, R. G.; Heys, S. D.

In: Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 85, No. 6, 12.2011, p. 305-310.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines

AU - Brown, I.

AU - Wahle, K. W. J.

AU - Cascio, M. G.

AU - Smoum-Jaouni, R.

AU - Mechoulam, R.

AU - Pertwee, R. G.

AU - Heys, S. D.

PY - 2011/12

Y1 - 2011/12

N2 - Omega-3 (n-3) fatty acids inhibit breast and prostate cancer cell growth. We previously showed that N-acylethanolamine derivatives of n-3 (n-3-NAE) are endocannabinoids, which regulate cancer cell proliferation. These n-3-NAE are synthesised in certain cells/tissues, after supplementing with fatty acids, however, no one has assessed whether and to what extent this occurs in cancer cells. We determined levels of endogenous n-3-NAEs in hormone sensitive and insensitive prostate and breast cancer cells and subsequent effects on other endocannabinoids (anandamide and 2-arachidonoylglycerol), before and after supplementing with DHA and EPA fatty acids, using HPLC tandem mass spectrometry. This is the first study reporting that n-3-NAEs are synthesised from their parent n-3 fatty acids in cancer cells, regardless of tumour type, hormone status or the presence of fatty acid amide hydrolase. This could have important implications for the use of n-3 fatty acids as therapeutic agents in breast and prostate cancers expressing cannabinoid receptors.

AB - Omega-3 (n-3) fatty acids inhibit breast and prostate cancer cell growth. We previously showed that N-acylethanolamine derivatives of n-3 (n-3-NAE) are endocannabinoids, which regulate cancer cell proliferation. These n-3-NAE are synthesised in certain cells/tissues, after supplementing with fatty acids, however, no one has assessed whether and to what extent this occurs in cancer cells. We determined levels of endogenous n-3-NAEs in hormone sensitive and insensitive prostate and breast cancer cells and subsequent effects on other endocannabinoids (anandamide and 2-arachidonoylglycerol), before and after supplementing with DHA and EPA fatty acids, using HPLC tandem mass spectrometry. This is the first study reporting that n-3-NAEs are synthesised from their parent n-3 fatty acids in cancer cells, regardless of tumour type, hormone status or the presence of fatty acid amide hydrolase. This could have important implications for the use of n-3 fatty acids as therapeutic agents in breast and prostate cancers expressing cannabinoid receptors.

KW - eicosapentaenoic acid

KW - cannabinoid receptors

KW - anandamide

KW - ethanolamides

KW - proliferation

KW - apoptosis

KW - supplementation

KW - n-3 pufa

KW - prostate cancer

KW - endocannabinoid

KW - brain

KW - growth

KW - breast cancer

KW - n-acylethanolamine

KW - polyunsaturated fatty-acids

UR - http://www.scopus.com/inward/record.url?scp=80055068558&partnerID=8YFLogxK

U2 - 10.1016/j.plefa.2011.09.007

DO - 10.1016/j.plefa.2011.09.007

M3 - Article

VL - 85

SP - 305

EP - 310

JO - Prostaglandins, Leukotrienes and Essential Fatty Acids

T2 - Prostaglandins, Leukotrienes and Essential Fatty Acids

JF - Prostaglandins, Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 6

ER -